When to Repeat a Thyroid Ultrasound — Surveillance Intervals

Introduction

Thyroid ultrasound is a crucial diagnostic tool in the management of thyroid nodules and other thyroid conditions. It provides detailed images of the thyroid gland, helping clinicians assess nodule size, characteristics, and potential malignancy. However, the question of "when to repeat a thyroid ultrasound" is equally important, guiding long-term surveillance and preventing unnecessary procedures while ensuring timely detection of significant changes. This article delves into the clinical guidelines, patient considerations, and practical aspects of thyroid ultrasound surveillance intervals.

Understanding Thyroid Nodules and Surveillance

Thyroid nodules are common, with prevalence increasing with age. Most are benign, but a small percentage can be malignant. Ultrasound is the primary imaging modality for evaluating these nodules. The Thyroid Imaging Reporting and Data System (TI-RADS) is a widely adopted stratification system that categorizes thyroid nodules based on their ultrasound features, assigning a score that correlates with the risk of malignancy. This system, along with nodule size, plays a pivotal role in determining the appropriate surveillance interval.

Clinical Explanations: Anatomy and Pathology

The thyroid gland, a butterfly-shaped endocrine organ located at the base of the neck, plays a vital role in regulating metabolism through the production of thyroid hormones. Its intricate anatomy, including its two lobes connected by an isthmus, and its proximity to critical structures like the trachea, esophagus, and recurrent laryngeal nerves, makes precise imaging and assessment paramount. Pathologically, thyroid nodules can range from benign colloid cysts and adenomas to various forms of thyroid cancer, including papillary, follicular, medullary, and anaplastic carcinomas. Understanding the microscopic features and growth patterns of these pathologies is essential for interpreting ultrasound findings and guiding surveillance strategies.

The Patient Experience During a Thyroid Ultrasound

A thyroid ultrasound is a non-invasive, painless procedure. Patients typically lie on their back with their neck extended, often with a pillow placed under their shoulders. A clear gel is applied to the neck, and a small transducer is moved across the skin to capture images of the thyroid gland. The procedure usually takes about 15-30 minutes. Patients may feel slight pressure from the transducer but generally experience no discomfort. The sonographer or radiologist will explain the process and may ask the patient to remain still or swallow during certain parts of the examination.

Surveillance Intervals: Guidelines and Considerations

The decision to repeat a thyroid ultrasound is based on several factors, including the initial TI-RADS classification, nodule size, patient risk factors, and changes observed in previous scans.

TI-RADS Categories and Recommended Intervals

TI-RADS 1 (Benign): No follow-up generally required.
TI-RADS 2 (Not Suspicious): No routine follow-up unless clinical concerns arise.
TI-RADS 3 (Mildly Suspicious): Follow-up ultrasound typically at 1-2 years, then every 3-5 years if stable.
TI-RADS 4 (Moderately Suspicious): Follow-up ultrasound at 6-12 months, then every 1-2 years if stable.
TI-RADS 5 (Highly Suspicious): Biopsy recommended. If benign, follow-up at 6-12 months, then annually for several years.

Nodule Size and Growth

Significant growth of a thyroid nodule is a key indicator for repeat evaluation. A 20% increase in two dimensions with a minimum increase of 2 mm, or a 50% increase in volume, are commonly cited criteria for significant growth that warrants further investigation or biopsy.

From Our Practice: Anonymised Clinical Scenarios

Here, we present anonymised clinical scenarios that illustrate the application of surveillance guidelines in real-world practice.

Scenario 1: Stable TI-RADS 3 Nodule

A 45-year-old female presented with a 1.5 cm thyroid nodule classified as TI-RADS 3. Initial biopsy was benign. Subsequent ultrasound at 1 year showed no significant change in size or characteristics. The patient was advised to have another follow-up ultrasound in 3 years.

⚠ Red Flags: When to Seek Immediate Attention

Patients should be aware of certain

symptoms that may indicate a change in their thyroid condition, such as:

Rapidly growing neck mass: A sudden increase in the size of a lump in the neck.
Difficulty swallowing or breathing: Compression of the esophagus or trachea by a growing nodule.
Hoarseness or voice changes: Involvement of the recurrent laryngeal nerve.
Persistent neck pain: Localized pain that does not resolve.

Deeper Clinical Explanations: Thyroid Anatomy and Pathology

The Thyroid Gland: A Master Regulator

The thyroid gland is a highly vascularized endocrine organ, typically weighing between 15-30 grams in adults. It is composed of numerous follicles, which are spherical structures lined by follicular cells that synthesize and secrete thyroid hormones (thyroxine or T4, and triiodothyronine or T3). These hormones are critical for regulating basal metabolic rate, protein synthesis, and sensitivity to other hormones. Parafollicular C cells, interspersed among the follicular cells, produce calcitonin, a hormone involved in calcium homeostasis. The gland's rich blood supply, primarily from the superior and inferior thyroid arteries, is crucial for its function and can be visualized during Doppler ultrasound, providing insights into nodule vascularity.

Pathological Spectrum of Thyroid Nodules

Thyroid nodules represent a diverse group of lesions, each with distinct pathological features that influence their ultrasound appearance and clinical significance.

Colloid Cysts: These are benign, fluid-filled sacs resulting from the accumulation of colloid within thyroid follicles. On ultrasound, they typically appear anechoic (black) with posterior acoustic enhancement, often containing small echogenic foci representing inspissated colloid. Their benign nature usually precludes the need for extensive follow-up.

Follicular Adenomas: These are benign encapsulated tumors of follicular cells. Differentiating follicular adenomas from follicular carcinomas preoperatively can be challenging, as both may exhibit similar ultrasound features (e.g., solid, hypoechoic nodules). Definitive diagnosis often requires surgical excision and histological examination. Surveillance for these nodules focuses on monitoring for growth or suspicious changes.

Papillary Thyroid Carcinoma (PTC): The most common type of thyroid cancer, PTC typically presents as a solid, hypoechoic nodule with irregular margins, microcalcifications (punctate echogenic foci), and often taller-than-wide shape. Central and lateral neck lymphadenopathy is a common finding. Understanding these characteristic ultrasound features is paramount for early detection and appropriate management.

Follicular Thyroid Carcinoma (FTC): Less common than PTC, FTC often appears as a solid, hypoechoic nodule, similar to follicular adenomas. The presence of capsular or vascular invasion is required for a definitive diagnosis of malignancy, which cannot be reliably assessed by ultrasound alone. Therefore, suspicious follicular lesions often warrant fine-needle aspiration (FNA) and potentially surgical removal.

Medullary Thyroid Carcinoma (MTC): Arising from the parafollicular C cells, MTC can be sporadic or hereditary. Ultrasound features can vary but often include solid, hypoechoic nodules with calcifications. Elevated serum calcitonin levels are a key biochemical marker. Surveillance involves monitoring for nodule growth and regional lymph node involvement.

Anaplastic Thyroid Carcinoma (ATC): A rare but highly aggressive form of thyroid cancer, ATC typically presents as a rapidly growing, large, invasive mass with irregular margins and often extensive extrathyroidal extension. Ultrasound findings usually reflect its aggressive nature, showing invasion into surrounding structures. Due to its rapid progression, immediate intervention is critical.

The Role of Ultrasound in Pathological Assessment

Ultrasound plays a critical role in characterizing these pathologies by evaluating several key features:

Echogenicity: How bright or dark the nodule appears relative to the surrounding thyroid tissue. Hypoechoic nodules (darker) are more suspicious.
Margins: Irregular or microlobulated margins are concerning for malignancy.
Calcifications: Microcalcifications are highly suggestive of papillary thyroid cancer.
Shape: A taller-than-wide shape in the transverse view is a suspicious feature.
Vascularity: Increased internal vascularity on Doppler ultrasound can be associated with malignancy.
Extrathyroidal Extension: Invasion of the nodule beyond the thyroid capsule into surrounding tissues is a strong indicator of malignancy.
Lymph Node Status: Evaluation of cervical lymph nodes for suspicious features (e.g., rounded shape, loss of fatty hilum, microcalcifications, cystic changes) is crucial for staging and management.

These detailed ultrasound characteristics, when combined with clinical history and patient risk factors, guide the decision-making process for FNA biopsy and subsequent surveillance strategies. The dynamic nature of thyroid pathology necessitates vigilant and appropriately timed follow-up ultrasounds to detect subtle changes that may indicate disease progression or transformation.

The Patient Experience During a Thyroid Ultrasound: A Detailed Walkthrough

Undergoing a thyroid ultrasound is a straightforward and generally comfortable procedure. Understanding each step can help alleviate any anxieties and ensure a smooth experience.

Before the Scan: Preparation and Arrival

Typically, there is no special preparation required for a thyroid ultrasound. Patients can eat, drink, and take their medications as usual. It is advisable to wear comfortable clothing that allows easy access to the neck area. Patients should inform the sonographer or radiologist about any relevant medical history, including previous thyroid conditions, surgeries, or medications, as well as any symptoms they might be experiencing, such as neck pain, difficulty swallowing, or voice changes. Upon arrival at the clinic, patients will usually be asked to complete some paperwork and may have a brief consultation with a nurse or technician to confirm their details and explain the procedure once more.

During the Scan: What to Expect

1. Positioning: The patient will be asked to lie on their back on an examination table. To ensure optimal visualization of the thyroid gland, a small pillow or rolled towel is often placed under the shoulders to gently extend the neck. This position helps to bring the thyroid gland forward and make it more accessible for the ultrasound transducer.

2. Gel Application: A clear, water-based gel will be applied to the skin of the neck. This gel is essential as it eliminates air pockets between the transducer and the skin, allowing sound waves to travel effectively and produce clear images. The gel is hypoallergenic and easily wiped off after the procedure.

3. Transducer Movement: A small, handheld device called a transducer will be gently moved across the skin of the neck. This transducer emits high-frequency sound waves that bounce off the thyroid gland and surrounding structures, creating real-time images on a monitor. The sonographer will systematically scan different areas of the thyroid, including both lobes and the isthmus, as well as the adjacent lymph nodes in the neck. They may apply slight pressure to obtain better images, which should not be painful but might feel a little firm.

4. Instructions and Communication: Throughout the procedure, the sonographer or radiologist will communicate with the patient. They may ask the patient to remain very still, hold their breath briefly, or even swallow. Swallowing helps to move the trachea and esophagus, allowing for clearer views of the thyroid gland. Patients are encouraged to voice any discomfort or questions they may have during the scan.

5. Duration: A typical thyroid ultrasound takes approximately 15 to 30 minutes. The exact duration can vary depending on the complexity of the findings and the number of nodules present.

After the Scan: Post-Procedure and Results

Once the imaging is complete, the gel will be wiped off the patient's neck. Patients can immediately resume their normal activities, as there are no restrictions following a thyroid ultrasound. The ultrasound images will then be reviewed by a radiologist, who will prepare a detailed report. This report will describe the size, location, and characteristics of any nodules found, as well as an assessment of the surrounding lymph nodes. The results are typically sent to the referring physician, who will then discuss the findings and the next steps, including any recommendations for follow-up or further investigations, such as a fine-needle aspiration (FNA) biopsy if suspicious nodules are identified. The waiting time for results can vary, but patients are usually informed within a few days to a week. It is important for patients to schedule a follow-up appointment with their doctor to discuss the results and formulate a personalized management plan.

Scenario 2: New TI-RADS 4 Nodule in a High-Risk Patient

A 38-year-old male with a family history of medullary thyroid carcinoma presented for a routine check-up. A new 0.8 cm nodule was identified on ultrasound, classified as TI-RADS 4 due to its hypoechogenicity and microlobulated margins. Given the family history and suspicious ultrasound features, a fine-needle aspiration (FNA) biopsy was performed, which confirmed papillary thyroid carcinoma. This case highlights the importance of considering patient risk factors and aggressive follow-up for suspicious new lesions.

Scenario 3: Growing TI-RADS 3 Nodule Requiring Re-evaluation

A 62-year-old female had a 1.2 cm TI-RADS 3 nodule that had been stable for 3 years. At her most recent annual ultrasound, the nodule measured 1.8 cm with a 30% increase in its largest dimension. Although still classified as TI-RADS 3, the significant growth prompted a repeat FNA biopsy, which revealed benign cytology. Despite the benign result, due to the growth, a shorter follow-up interval of 6 months was recommended to ensure continued stability.

Scenario 4: Multiple Benign Nodules with No Suspicious Features

A 55-year-old male presented with multiple thyroid nodules, the largest being 2.5 cm, all classified as TI-RADS 2. All nodules were isoechoic with smooth margins and no suspicious features. Given the benign characteristics and lack of significant growth over two years of initial surveillance, the patient was advised that routine follow-up ultrasounds were no longer necessary, and he could be discharged from active surveillance unless new symptoms developed. This scenario demonstrates when discharge from surveillance is appropriate for clearly benign lesions.

Scenario 5: Post-Thyroidectomy Surveillance for Recurrence

A 48-year-old female underwent total thyroidectomy for papillary thyroid carcinoma five years prior. Her initial post-operative surveillance ultrasounds were unremarkable. However, a recent ultrasound revealed a new 0.5 cm hypoechoic nodule in the thyroid bed, classified as TI-RADS 4. This finding prompted an immediate FNA, which confirmed recurrent papillary thyroid carcinoma. This case underscores the necessity of continued surveillance, even after thyroidectomy, especially in patients with a history of thyroid cancer, and the vigilance required for new suspicious lesions in the surgical bed.

Comprehensive FAQs: Addressing Common Patient Concerns

Q1: Is a thyroid ultrasound painful?

No, a thyroid ultrasound is generally a painless procedure. You might feel a slight pressure as the sonographer moves the transducer over your neck, but it should not cause discomfort. The gel used is water-based and hypoallergenic.

Q2: How long does a thyroid ultrasound take?

The procedure typically takes between 15 to 30 minutes, depending on the complexity of your thyroid anatomy and the number of nodules that need to be evaluated.

Q3: Do I need to prepare for a thyroid ultrasound?

No special preparation is usually required. You can eat, drink, and take your medications as normal. Wearing comfortable clothing that allows easy access to your neck is recommended.

Q4: What do the TI-RADS categories mean?

TI-RADS (Thyroid Imaging Reporting and Data System) is a scoring system used by radiologists to assess the risk of malignancy in thyroid nodules based on their ultrasound features. The categories range from TI-RADS 1 (benign) to TI-RADS 5 (highly suspicious for malignancy), with higher numbers indicating a greater need for further investigation like biopsy.

Q5: What if my nodule grows?

Significant growth of a thyroid nodule, typically defined as a 20% increase in two dimensions with a minimum increase of 2 mm, or a 50% increase in volume, often warrants a repeat evaluation or biopsy, even if the nodule was previously deemed benign. Your doctor will assess the growth in the context of your overall clinical picture.

Q6: When is a biopsy recommended?

A fine-needle aspiration (FNA) biopsy is generally recommended for nodules that are classified as TI-RADS 4 or 5, or for TI-RADS 3 nodules that are larger than a certain size (e.g., >1.5-2 cm) or show significant growth. Your doctor will discuss the specific indications for biopsy based on your ultrasound findings and risk factors.

Q7: Can a benign nodule become cancerous?

While most benign nodules remain benign, there is a very small chance that some can undergo malignant transformation over a long period. This is why regular surveillance, especially for larger or mildly suspicious nodules, is important. However, it is more common for a nodule initially thought to be benign to be reclassified as suspicious upon closer examination or due to new growth.

Q8: What are the

signs that I should seek immediate medical attention?

You should seek immediate medical attention if you experience a rapidly growing neck mass, difficulty swallowing or breathing, hoarseness or voice changes, or persistent neck pain. These symptoms could indicate a significant change in your thyroid condition that requires prompt evaluation.

Q9: Will I need to have ultrasounds for the rest of my life?

Not necessarily. The need for ongoing surveillance depends on the characteristics of your nodules and your overall risk profile. For many patients with stable, benign-appearing nodules, surveillance can eventually be discontinued. Your doctor will advise you on the appropriate long-term plan based on your specific situation.

Q10: How do I know if my ultrasound results are accurate?

Ultrasound is a highly operator-dependent modality, meaning the accuracy of the results relies heavily on the skill and experience of the sonographer and the radiologist interpreting the images. It is important to have your ultrasound performed at a reputable facility with experienced professionals. If you have concerns about your results, you can always seek a second opinion.

Conclusion

Determining when to repeat a thyroid ultrasound is a nuanced decision that requires careful consideration of various clinical factors, including the TI-RADS classification, nodule size, patient risk factors, and any changes observed over time. By understanding the underlying anatomy and pathology, the patient experience during the scan, and the guidelines for surveillance intervals, patients can actively participate in their care and make informed decisions. Regular follow-up, when indicated, is crucial for the timely detection of significant changes and the appropriate management of thyroid conditions.

References

[1] Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., ... & Wartofsky, L. (2016). 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid, 26(1), 1-133.

[2] Tessler, F. N., Middleton, W. D., Grant, E. G., Hoang, J. K., Berland, L. L., Teefey, S. A., ... & Beland, M. D. (2017). ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. Journal of the American College of Radiology, 14(5), 587-595.

[3] Perros, P., Boelaert, K., Colley, S., Evans, C., Evans, R. M., Gerrard Ba, G., ... & British Thyroid Association. (2014). Guidelines for the management of thyroid cancer. Clinical endocrinology, 81(S1), 1-122.

Call to Action

If you have concerns about a thyroid nodule or have been advised to undergo a follow-up ultrasound, our team of experienced specialists at IUS London is here to provide comprehensive and compassionate care. Contact us today to schedule your appointment and ensure your thyroid health is expertly managed.

Book Your Private Ultrasound Scan in London

Same-day appointments available in Kensington. No GP referral required. HCPC-registered consultant sonographers.